BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29344924)

  • 1. Reliability of the
    Bateman TM; Ananthasubramaniam K; Berman DS; Gerson M; Gropler R; Henzlova M; Mendoza F; Miyamoto M; Shah M; Weiland F
    J Nucl Cardiol; 2019 Oct; 26(5):1555-1565. PubMed ID: 29344924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in Heart-to-Mediastinum Ratio from Planar
    Owenius R; Zanette M; Cella P
    J Nucl Med Technol; 2017 Dec; 45(4):297-303. PubMed ID: 29042467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First determination of the heart-to-mediastinum ratio using cardiac dual isotope (¹²³I-MIBG/⁹⁹mTc-tetrofosmin) CZT imaging in patients with heart failure: the ADRECARD study.
    Bellevre D; Manrique A; Legallois D; Bross S; Baavour R; Roth N; Blaire T; Desmonts C; Bailliez A; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1912-9. PubMed ID: 26227533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
    Agostini D; Verberne HJ; Burchert W; Knuuti J; Povinec P; Sambuceti G; Unlu M; Estorch M; Banerjee G; Jacobson AF
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):535-46. PubMed ID: 18043919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
    Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
    Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.
    Veltman CE; Boogers MJ; Meinardi JE; Al Younis I; Dibbets-Schneider P; Van der Wall EE; Bax JJ; Scholte AJ
    Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1599-608. PubMed ID: 22790878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.
    Dimitriu-Leen AC; Gimelli A; Al Younis I; Veltman CE; Verberne HJ; Wolterbeek R; Zandbergen-Harlaar S; Bax JJ; Scholte AJHA
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):326-332. PubMed ID: 26515715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT.
    Clements IP; Garcia EV; Chen J; Folks RD; Butler J; Jacobson AF
    J Nucl Cardiol; 2016 Jun; 23(3):425-35. PubMed ID: 25788403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.
    Pellegrino T; Petretta M; De Luca S; Paolillo S; Boemio A; Carotenuto R; Petretta MP; di Nuzzo C; Perrone-Filardi P; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1549-57. PubMed ID: 23740373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
    Verberne HJ; Habraken JB; van Eck-Smit BL; Agostini D; Jacobson AF
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):547-53. PubMed ID: 17922122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the Heart-to-Mediastinum Ratio of
    Blaire T; Bailliez A; Ben Bouallegue F; Bellevre D; Agostini D; Manrique A
    J Nucl Med; 2018 Feb; 59(2):251-258. PubMed ID: 28646015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies.
    Somsen GA; Borm JJ; Dubois EA; Schook MB; Van Der Wall EE; Van Royen EA
    Nucl Med Commun; 1996 Oct; 17(10):872-6. PubMed ID: 8951908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.